These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 33530209)
1. Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma. Meng D; Liu T; Ma F; Wang M Medicine (Baltimore); 2021 Jan; 100(4):e24184. PubMed ID: 33530209 [TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580 [TBL] [Abstract][Full Text] [Related]
3. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma. Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115 [TBL] [Abstract][Full Text] [Related]
4. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
5. Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma. He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150 [TBL] [Abstract][Full Text] [Related]
7. Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma. Zhao S; Peng M; Wang Z; Cao J; Zhang X; Yu R; Huang T; Lian W Dis Markers; 2022; 2022():1014347. PubMed ID: 36097539 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study. Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362 [TBL] [Abstract][Full Text] [Related]
9. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods. Jin Y; Yang Y Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688 [TBL] [Abstract][Full Text] [Related]
11. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis. Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621 [TBL] [Abstract][Full Text] [Related]
12. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients. Li J; Tang LL; Ma J BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785 [TBL] [Abstract][Full Text] [Related]
13. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
14. ANXA5 predicts prognosis and immune response and mediates proliferation and migration in head and neck squamous cell carcinoma. Yang D; Chen H; Zhou Z; Guo J Gene; 2024 Dec; 931():148867. PubMed ID: 39168258 [TBL] [Abstract][Full Text] [Related]
15. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival. Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-related signature to risk stratify patients for the benefit of immune checkpoint inhibitors therapy in head and neck squamous cell carcinoma: An experimental study. Zhao Y; Yang Z; Fu M; Wu S; Wang M; Li J; Wang Z; Li W Medicine (Baltimore); 2024 Aug; 103(31):e39184. PubMed ID: 39093745 [TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets. Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma. Yang C; Mei H; Peng L; Jiang F; Xie B; Li J Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497 [TBL] [Abstract][Full Text] [Related]
19. Peripheral immune signature resembles tumor microenvironment and predicts clinical outcomes in head and neck squamous cell carcinoma. Hu Z; Zhou J; Li Y; Luan Y; Li H; Jia B; Xie Z; Cheng B; Wu T Front Immunol; 2022; 13():915207. PubMed ID: 36148222 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma. Wang Z; Yuan H; Huang J; Hu D; Qin X; Sun C; Chen G; Wang B Head Neck; 2021 Jan; 43(1):182-197. PubMed ID: 33009692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]